Skip to main content
. 2016 Nov 25;8(1):1141–1155. doi: 10.18632/oncotarget.13588

Figure 3.

Figure 3

A. Objective response rate (ORR) of the studies; B. Subgroup analysis of ORR for angiogenesis inhibitors only targeting VEGF/VEGFR plus chemotherapy (CT) versus CT.